Maravai LifeSciences Holdings, Inc.
MRVI
$3.08
-$0.21-6.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.74% | 73.67% | -304.44% | -147.93% | 75.55% |
| Total Depreciation and Amortization | 1.43% | 10.00% | 5.77% | 8.41% | 11.91% |
| Total Amortization of Deferred Charges | -38.75% | -47.08% | -47.45% | -37.70% | -11.44% |
| Total Other Non-Cash Items | 163.69% | -111.01% | 115.32% | -26.97% | -93.32% |
| Change in Net Operating Assets | -86.07% | 109.44% | -81.49% | 151.59% | -538.92% |
| Cash from Operations | -55.54% | -215.33% | -158.88% | -10.90% | -287.91% |
| Capital Expenditure | 63.86% | 65.94% | 69.92% | 7.59% | 65.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 100.00% | -100.00% | -48.35% | -76.44% |
| Cash from Investing | 57.13% | 67.34% | 47.65% | -444.98% | 61.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.66% | -2.63% | -2.59% | -2.52% | -15,203.60% |
| Issuance of Common Stock | 211.35% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -230.22% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 27.85% | -389.61% | -100.00% | -42.18% | -436.16% |
| Cash from Financing | 99.23% | -1,119.65% | -772.81% | -775.00% | -50,352.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.57% | -628.14% | -231.93% | -181.41% | -5,408.46% |